Tag: cancer
-
Project to Catalog Precision Lung Cancer Immunotherapies
A new research initiative in the U.K. is collecting and mapping precise combinations of therapies that invoke the immune system to treat lung cancer.
-
FDA Approves Biomarker-Targeting Cancer Drug
The Food and Drug Administration yesterday approved a treatment for solid tumor cancers that focuses on specific cancer-causing genetic conditions rather than location of the cancer in the body.
-
Survey Shows Sharp Rise in Teen E-Cigarette Use
New data from a continuing survey of smoking among school-age children shows large increases in electronic cigarette use in high school and middle school children in just the past year.
-
Biotechs to Develop Personal Cancer-Killing Virus Vaccines
Two biotechnology companies developing engineered viruses as cancer therapies plan to create personalized treatments for solid tumors with viruses that harness the immune system.
-
Trials Evaluating Blood Tests to Guide Cancer Treatment
Researchers in Australia are conducting clinical trials of blood tests among cancer patients to help determine the course of their treatment, including the need for chemotherapy.
-
Six Ideas for Combating Cancer, the Emperor of Maladies
There are advancements in medicine every day that allow for new treatments and discoveries to emerge in the battle against cancer.
-
Cancer Antibody Trials Stopped After Patient Death
Two clinical trials testing synthetic antibodies designed to treat blood-related cancers were stopped by their developer after a participant in one trial died from adverse effects.
-
Start-Up Developing Immunometabolism Therapies, Gains $30M Funding
A start-up enterprise founded by medical researchers in the U.S. and Europe is developing treatments for cancer and autoimmune disorders that change chemical reactions in immune system cells.
-
FDA Clears Genomic Bone Marrow Test for Low-Level Cancer
1 Oct. 2018. The Food and Drug Administration on Friday authorized for marketing in the U.S. a system for high-speed analysis of bone marrow samples to find low levels of residual cancer cells. The agency’s announcement cleared the ClonoSeq assay developed by Adaptive Biotechnologies in Seattle to test for minimal residual disease levels in people…
-
Genome Centers Named for Precision Medicine Program
Three medical research centers in the U.S. will begin analyzing the DNA in specimen samples from participants in a large-scale precision medicine initiative conducted by National Institutes of Health.